Cargando…
Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness
SIMPLE SUMMARY: Given the rising mortality rate caused by GBM, current therapies do not appear to be effective in counteracting tumor progression. The role of adenosine and its interaction with specific receptor subtypes in various physiological functions has been studied for years. Only recently, a...
Autores principales: | Bova, Valentina, Filippone, Alessia, Casili, Giovanna, Lanza, Marika, Campolo, Michela, Capra, Anna Paola, Repici, Alberto, Crupi, Lelio, Motta, Gianmarco, Colarossi, Cristina, Chisari, Giulia, Cuzzocrea, Salvatore, Esposito, Emanuela, Paterniti, Irene |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406358/ https://www.ncbi.nlm.nih.gov/pubmed/36011024 http://dx.doi.org/10.3390/cancers14164032 |
Ejemplares similares
-
Therapeutic Potential of Dimethyl Fumarate in Counteract Oral Squamous Cell Carcinoma Progression by Modulating Apoptosis, Oxidative Stress and Epithelial–Mesenchymal Transition
por: Basilotta, Rossella, et al.
Publicado: (2023) -
Dimethyl Fumarate (DMF) Alleviated Post-Operative (PO) Pain through the N-Methyl-d-Aspartate (NMDA) Receptors
por: Casili, Giovanna, et al.
Publicado: (2022) -
The Pivotal Role of Protein Phosphatase 2A (PP2A) in Brain Tumors
por: Cucinotta, Laura, et al.
Publicado: (2022) -
Potential Therapeutic Effects of PPAR Ligands in Glioblastoma
por: Basilotta, Rossella, et al.
Publicado: (2022) -
TAK1 Inhibitor Enhances the Therapeutic Treatment for Glioblastoma
por: Campolo, Michela, et al.
Publicado: (2020)